MET Amplification
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lorlatinib Combinations in Lung Cancer (NCT04292119) | Massachusetts General Hospital | 2020-05-01 |
| Tepotinib in Solid Tumors Harboring MET Alterations (NCT04647838) | Chungbuk National University Hospital | 2020-01-16 |
| Study of Crizotinib for ROS1 and MET Activated Lung Cancer (NCT04084717) | University Health Network, Toronto | 2019-12-03 |
| APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (NCT03175224) | Apollomics Inc. | 2017-09-27 |
Track MET Amplification automatically
Every clearance here is in the API, with alerts when new ones post.